Currently out of the existing stock ratings of Aydin Huseynov, 53 are a BUY (80.3%), 13 are a HOLD (19.7%).

Aydin Huseynov

Work Performance Price Targets & Ratings Chart

Analyst Aydin Huseynov, currently employed at LADENBURG, carries an average stock price target met ratio of 51% that have a potential upside of 80.54% achieved within 373 days. Previously, Aydin Huseynov worked at BENCHMARK.

Aydin Huseynov’s has documented 120 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on CAPR, Capricor Therapeutics at 31-Jul-2026.

Wall Street Analyst Aydin Huseynov

Analyst best performing recommendations are on NRBO (NEUROBO PHARMACEUTICALS).
The best stock recommendation documented was for NRBO (NEUROBO PHARMACEUTICALS) at 12/13/2022. The price target of $6 was fulfilled within 15 days with a profit of $7.2 (54.55%) receiving and performance score of 36.36.

Average potential price target upside

of $266.75 (54.93%) on PALI (PALISADE BIO).
of $193.64 (79.56%) on NXTC (NEXTCURE ).
of $75.18 (13.26%) on REGN (REGENERON PHARMACEUTICALS).

CALA Calithera Biosciences INCY yte INO Inovio Pharmaceuticals NKTR Nektar Therapeutics REGN Regeneron Pharmaceuticals SLS Sellas Life Sciences Group SPRB Spruce Biosciences VYGR Voyager Therapeutics NXTC NextCure ALLR Allarity Therapeutics ATHE Alterity Therapeutics Ltd CMPX Compass Therapeutics PCSA Processa Pharmaceuticals TRIL Trillium Therapeutics PALI Palisade Bio CRVS Corvus Pharmaceuticals CGTX Cognition Therapeutics TPST Tempest Therapeutics CAPR Capricor Therapeutics MRKR Marker Therapeutics ACRV Acrivon Therapeutics, Common Stock ALRN Aileron Therapeutics IONS Ionis Pharmaceuticals CAL Caleres NRBO Neurobo Pharmaceuticals QNRX Quoin Pharmaceuticals Ltd DRC CLDI Calidi Biotherapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Jonathan Chang (LEERINK)